3Rocha R,Williams GH.Rationale for the use of aldosterone antagonists in congestive heart failure.Drugs,2002,62(5):723-731
4Hayashi M,Tsutamoto T,Wada A,et al.Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction.Circulation,2003,107(20):2559-2565
5Bauersachs J,Heck M,Fraccarollo D,et al.Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction:role of vascular superoxide anion formation and endothelial nitric oxide synthase expression.J Am Coll Cardiol,2002,39(2):351-358
6Pitt B,Zannad F,Remme WJ,et al.The effect of spironolactone on morbidity and mortality in patients with severe heart failure.N Engl J Med,1999,341(10):709-717
7Pitt B,Remme W,Zannad F,et al.Eplerenone,a selective aldosterone blocker,in patients with left ventricular dysfunction after myocardial infarction.N Engl J Med,2003,348(14):1309-1321
8Cicoira M,Zanolla L,Rossi A,et al.Long-term,dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure.J Am Coll Cardiol,2002,40(2):304-310
9李延辉 那开宪.慢性心力衰竭的历史、现状和未来.中华临床杂志,2003,3(4):53-59.
10U. Hauf-Zachariou,L. Widmann,B. Zülsdorf,M. Hennig,P. D. Lang. A double-blind comparison of the effects of carvedilol and captopril on serum lipid concentrations in patients with mild to moderate essential hypertension and dyslipidaemia[J] 1993,European Journal of Clinical Pharmacology(2):95～100
